Related Experiment Video

Updated: Jun 17, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Amphiregulin drives EGFR-dependent genome stability in colorectal cancer and represents a targetable vulnerability

Sun-Ji Park1, Sung-Woo Lee2,3, Heegyum Moon4

  • 1Department of Physiology, Jeonbuk National University Medical School, Jeonju, Republic of Korea.

Oncogene
|June 15, 2026
PubMed

Insights

Amphiregulin (AREG) is highly expressed in colorectal cancer (CRC) and moves into the nucleus, impacting DNA repair. AREG depletion significantly reduces CRC proliferation and tumor growth, suggesting it

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Amphiregulin (AREG) is an epidermal growth factor receptor (EGFR) ligand involved in cell signaling.
  • AREG's role in colorectal cancer (CRC) and its nuclear functions are not fully understood.

Purpose of the Study:

  • To investigate the role of AREG in colorectal cancer (CRC) progression.
  • To elucidate the nuclear functions of AREG and its impact on DNA replication and repair.

Main Methods:

  • Immunohistochemistry and Western blot to assess AREG expression in CRC.
  • siRNA and CRISPR-Cas9 to deplete AREG.
  • Transcriptomic analysis to identify associated genes.
  • Xenograft models to evaluate tumor growth.

Main Results:

  • High AREG expression observed in CRC tumors.
  • AREG translocates into the nucleus, potentially via inhibited endocytosis.
  • AREG depletion causes cell cycle arrest and DNA replication defects.
  • AREG knockout reduces tumor growth and EGFR signaling pathway activation in vivo.
  • Combined AREG loss and EGFR inhibition show enhanced antitumor effects.

Conclusions:

  • AREG plays a significant role in CRC proliferation and genome maintenance.
  • AREG acts as a mediator of EGFR signaling and DNA repair in CRC.
  • Targeting AREG, potentially in combination with EGFR inhibitors, could be a therapeutic strategy for CRC.

More Related Videos

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...